Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-03
2009-08-25
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S469000, C514S414000, C514S557000
Reexamination Certificate
active
07579370
ABSTRACT:
This invention provides fused heterocycles having the formula:in which R1is a member selected from the group consisting of H, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R2is a member selected from the group consisting of H substituted or unsubstituted alkenyl, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R3is a member selected from the group consisting of H, C1-C6substituted or unsubstituted alkyl, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R4is a member selected from OH and O−X+, in which X+is positive ion which is a member selected from organic positive ions and inorganic positive ions. Substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl moieties have the formula:in which Ar is a member selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl. The index n is an integer from 1 to 4.
REFERENCES:
patent: 6479527 (2002-11-01), Barker et al.
patent: 6576653 (2003-06-01), Du Bois
patent: 7226938 (2007-06-01), Cai
patent: 2002/0183369 (2002-12-01), Du Bois
patent: 2003/0195361 (2003-10-01), Du Bois
patent: 2003/0215523 (2003-11-01), Ozawa
patent: 2006/0235002 (2006-10-01), Nagai
patent: 2007/0100135 (2007-05-01), Riggs
patent: 2007/0142452 (2007-06-01), Banner et al.
patent: 1391460 (2004-02-01), None
patent: WO 99/40914 (1999-08-01), None
patent: WO 03/039540 (2003-05-01), None
patent: WO 2004/022537 (2004-03-01), None
patent: WO 2005/066135 (2005-07-01), None
patent: WO 2006/004040 (2006-01-01), None
patent: WO 2006/077412 (2006-07-01), None
patent: WO 2007/039773 (2007-04-01), None
patent: WO 2007039773 (2007-04-01), None
patent: WO 2007/068621 (2007-06-01), None
STN Registry File No. 67268-37-5. Registry File. Retrieved from STN 2008-03-17. One page.
Bobosik et al. Synthesis of N-Phenylsulfonyl Protected Furo[3,2-b] Pyroles,Collect. Czech. Chem. Commun.(vol. 59) pp. 499-502 (1994).
Cyranski et al. “Aromaticity of dihertero analogues of pentalene dianion. X-ray and ab initio studies of eight methyl furo[3,2-b]pyrrole-5-carboxylate derivatives and five methyl furo[2,3-b]pyrrole-5-carboxylate derivatives”Tetrahedon57 8867-8873 (2001).
Dandarova, et al. “C NMR Spectra of Some Substituted Furo[3,2-b] pyrroles”Magnetic Resonance in Chemistry, vol. 28, 830-831 (1990).
Ferguson et al. “N-Acetyl-5,6-Dihydrofuro[3,2-b]Pyrid-2-One, C9H9NO3”Cryst. Struct. Comm.5, 911 (1976).
Fisera et al. “Correlation of Kinetic Data of 1,3-Dipolar Cycloadditions of C-Benzoyl-N-Phenylnitrones With the Homo Energies of Furan Derivatives”Collect. Czech. Chem. Commun.vol. 46, 1504-1512 (1981).
Fisera et al. “Cycloadditions of C-Benzoyl-N-Phenylnitrone with Furocondensed Derivatives”Collect. Czech. Chem. Commun.vol. 48, 2421-2427 (1981).
Fukuda, et al. “Tensidols, New Potentiators of Antifungal Miconazole Activity, Produced byAspergillus nigerFKI-2342”J. Antibiot59(8): 480-485 (2006).
Gross et al. “Direct Observation of 1-Azafulven-6-one and Annelated Derivatives”J. Chem. Soc. Chem. Commun.p. 360-361 (1982).
Hemetsberger et al. “Synthase und Thermolyse von α-Azidoacrylestern”Monatshefte für Chemie, 103, 194-204, (1972).
Ilyin et al. “Synthesis of Annelated Azaheterocycles Containing a 5-Carbamoylpyrazin-3-one Fragment by a Modification of the Four-Component Ugi Reaction”Eur. J. Org. Chem. 4670-4679 (2005).
Java et al. “Chimie Organique—Synthese de selnolo, furo et pyrrolpyrroles”C. R. Acad. Sc. Paris, t. 281 (Nov. 10, 1975) Serie C—793-795.
Koren et al. “Structure of a Furo[s,2-b]pyrrole Derivative”Acta. Cryst.C44, 2032-2033 (1988).
Kralovicova et al., “Electrophilic Substitution Reactions of Furo[3,2-b]Pyrrole Derivatives”Collect. Czech. Chem. Commun.(vol. 51) 106-111 (1986).
Krutosikova et al. “Addition and Cycloaddition Reactions of Furo[3,2-b]-Pyrroles and Their Benzo[b] Analogues: an NMR Study of Structure of Products”Collect. Czech. Chem. Commun.(vol. 53) 1770-1778 (1988).
Krutosikova et al. “Effect of microwave irradiation on reaction of furo[3,2-b]pyrrole and furo[2,3-b]pyrrole-2-carbeldehydes with some active methylene compounds”ARKIVOC(iii) 409-420 (2000).
Krutosikova et al. “Reactions of Ethyl 2-(4-Chlorophenyl)-4H-Furo[3,2-b]Pyrrole-5-Carboxylate”Collect. Czech. Chem. Commun.vol. 45, 2949-2957 (1980).
Krutosikova et al. “Reactions of furo[3,2-b]pyrroles and their benzol[b] analogues”,Chem Papers42 (1) 89-95 (1988).
Krutosikova et al. “Reactions of Methyl 2-Formylfuro[3,2-b]pyrrole-5-carboxylates”Chem Papers50 (2)72-76 (1996).
Krutosikova et al. “Substituted 4-Benzylfuro [3,2-b] Pyrroles”Collect. Czech. Chem. Commun.(vol. 57) 1487-1494 (1992).
Krutosikova et al. “Substituted Vinyl Azides in the Synthesis of Condensed Nitrogen Heterocycles”Chem Papers48 (4) 268-273 (1996).
Krutosikova et al. “Synthesis and reactions of 4-Oxiranylmethylfuro-[3,2-b]Pyrroles and their benzo derivatives”Chem. of Heterocyclic Compoundsvol. 37, No. 12, 1511-1517 (2001).
Krutosikova et al. “Synthesis and reactions of Furo[2,3-b]pyrroles”Molecules(2) 69-79 (1997).
Krutosikova et al. “Synthesis and Reactions of Furocondensed Derivatives”Collect. Czech. Chem. Commun.(vol. 49) 65-70 (1984).
Krutosikova et al. “Synthesis and Reactions of Substituted Furo[3,2-b]Pyrrole Derivatives”Collect. Czech. Chem. Commun. (vol. 46) 2564-2572 (1981).
New et al. “The Thieno [3.2-c]pyridine and Furo[3,2-c]pyridine rings: New Pharmacophonres with Potential Antipsychotic Acivity”J. Med. Chemvol. 32, 1147-1156 (1989).
Ogawa et al. “Preparation of Oxygen-Bridged AZA[15]- and AZA[17]Annulene Dicarboxylates by Intramuscular Azide Cyclization”Tetrahedon Letters, vol. 29, No. 2, pp. 219-222, 1988.
Puterova et al. “Reaction of Substituted Furan-2-carboxaldehydes and Furo[b]pyrrole Type Aldehydes with Hippuric Acid”Moleculesvol. 9, 11-21 (2004).
Puterova, et al. “Reactions of Substituted Furan-2-carboxaldehydes and Furo[b] pyrrole Type Aldehydes with Benzothiazolium Salts”Moleculesvol. 9, 241-255 (2004).
Romanova et al. “DC Polarographic and UV Spectrometric Studies of Substituted Furo[3,2-b]- and Furo[2,3-b]Pyrroles”Collect. Czech. Chem. Commun.(vol. 66) 1615-1622 (2001).
Sleziak et al. “Furo[2,3-b]Pyrrole Derivatives, Syntheses and Reactions in the Furan and Pyrrole Ring”Polish J. Chem.vol. 74, 207-217 (2000).
Sleziak et al. “Reactions of Furo[2,3-b]Pyrrole and Furo[3,2-b]Pyrrole-Type Aldehydes”Collect. Czech. Chem. Commun.(vol. 64) 1135-1146 (1999).
Sorotskaya et al. “The Series of Substituted Butenolides and Butenolides, IV. 4-Arylidene (Heteroarylidene)-2-Butenolides”Zhurnal Organicheskoi Khimiii, vol. 25, No. 1, pp. 175-182 (1989).
Soth et al. “Recherches en série hétérocylique. XXIX. Sur des voies d'accés á des tghiéno, sélénolo, furo et pyrrolopyrroles1”Can. J. Chem.vol. 56, 1429-1434, (1978).
Welch et al. “Improved Synthesis of [3,2-b] and [2,3-b]-fused Selenolo-and Thienopyrroles, and of Furo[3,2-b]pyrrole”Heterocyclic Communicationsvol. 5, No. 4, 305-310 (1999).
Dorsey James M.
Fang Qun Kevin
Foglesong Robert J.
Heffernan Michele L. R.
Hopkins Seth C.
Marschel Ardin
Morgan & Lewis & Bockius, LLP
Royds Leslie A
Sepracor Inc.
LandOfFree
Fused heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4104842